Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis

Clinical and Experimental Metastasis

Volumn 26, Issue 7, 2009, Pages 653-661

  Holmes, C E ^a   Levis, J E ^a   Ornstein, D L ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulation; Metastasis; Ovarian cancer; Platelets; Thrombin; Urokinase plasminogen activator; VEGF

Indexed keywords

PROSTAGLANDIN E1; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UROKINASE; VASCULOTROPIN;

ARTICLE; BLOOD CLOTTING; CANCER CELL CULTURE; CANCER INVASION; CELL ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; METASTASIS; OVARY CANCER; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOSIS;

CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PLATELET ACTIVATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 71849083241     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-009-9264-9     Document Type: Article

References (57)

1. MA Sarach RA Rovasio AR Eynard 1993 Platelet factors induce chemotactic migration of murine mammary adenocarcinoma cells with different metastatic capabilities Int J Exp Pathol 74 5 511 517 8217786
2. A Poggi E Vicenzi V Cioce, et al. 1988 Platelet contribution to cancer cell growth and migration: the role of platelet growth factors Haemostasis 18 1 18 28 3047020
3. C Belloc H Lu C Soria, et al. 1995 The effect of platelets on invasiveness and protease production of human mammary tumor cells Int J Cancer 60 3 413 417 10.1002/ijc.2910600324 10.1002/ijc.2910600324 7829253
4. JM Lewalle V Castronovo G Goffinet, et al. 1991 Malignant cell attachment to endothelium of ex vivo perfused human umbilical vein. Modulation by platelets, plasma and fibronectin Thromb Res 62 4 287 298 10.1016/0049-3848(91) 90149-Q 10.1016/0049-3848(91)90149-Q 1866711
5. B Felding-Habermann TE O'Toole JW Smith, et al. 2001 Integrin activation controls metastasis in human breast cancer Proc Natl Acad Sci USA 98 4 1853 1858 10.1073/pnas.98.4.1853 10.1073/pnas.98.4.1853 11172040 (Pubitemid 32165587)
6. DS Jones AC Wallace EE Fraser 1971 Sequence of events in experimental metastases of Walker 256 tumor: light, immunofluorescent, and electron microscopic observations J Natl Cancer Inst 46 3 493 504 4100699
7. GF Nash LF Turner MF Scully, et al. 2002 Platelets and cancer Lancet Oncol 3 7 425 430 10.1016/S1470-2045(02)00789-1 10.1016/S1470-2045(02)00789-1 12142172 (Pubitemid 36958273)
8. D Alonso-Escolano C Medina K Cieslik, et al. 2006 Protein kinase C{delta} mediates platelet-induced breast cancer cell invasion J Pharmacol Exp Ther 318 1 373 380 10.1124/jpet.106.103358 10.1124/jpet.106.103358 16617167 (Pubitemid 43920778)
9. A Boucharaba CM Serre S Gres, et al. 2004 Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer J Clin Invest 114 12 1714 1725 15599396
10. RK Assoian MB Sporn 1986 Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells J Cell Biol 102 4 1217 1223 10.1083/jcb.102.4.1217 10.1083/jcb.102.4.1217 3457014
11. HM Verheul K Hoekman S Luykx-de Bakker, et al. 1997 Platelet: transporter of vascular endothelial growth factor Clin Cancer Res 3 12 Pt 1 2187 2190 9815613
12. V Dubernard BB Arbeille MB Lemesle, et al. 1997 Evidence for an alpha-granular pool of the cytoskeletal protein alpha-actinin in human platelets that redistributes with the adhesive glycoprotein thrombospondin-1 during the exocytotic process Arterioscler Thromb Vasc Biol 17 10 2293 2305 9351403
13. KL Kaplan MJ Broekman A Chernoff, et al. 1979 Platelet alpha-granule proteins: studies on release and subcellular localization Blood 53 4 604 618 426909
14. JA Coppinger R O'Connor K Wynne, et al. 2007 Moderation of the platelet releasate response by aspirin Blood 109 11 4786 4792 10.1182/blood-2006-07- 038539 10.1182/blood-2006-07-038539 17303692 (Pubitemid 46827772)
15. L Ma R Perini W McKnight, et al. 2005 Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets Proc Natl Acad Sci USA 102 1 216 220 10.1073/pnas.0406682102 10.1073/pnas.0406682102 15615851 (Pubitemid 40094455)
16. LR Zacharski VA Memoli V Costantini, et al. 1990 Clotting factors in tumour tissue: implications for cancer therapy Blood Coagul Fibrinolysis 1 1 71 78 10.1097/00001721-199003000-00010 10.1097/00001721-199003000-00010 2102790
17. LR Zacharski VA Memoli DL Ornstein, et al. 1993 Tumor cell procoagulant and urokinase expression in carcinoma of the ovary J Natl Cancer Inst 85 15 1225 1230 10.1093/jnci/85.15.1225 10.1093/jnci/85.15.1225 8331683
18. E Bastida A Ordinas SL Giardina, et al. 1982 Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospholipase Cancer Res 42 11 4348 4352 6290033
19. G Konecny M Untch A Pihan, et al. 2001 Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer Clin Cancer Res 7 6 1743 1749 11410515
20. W Kuhn B Schmalfeldt U Reuning, et al. 1999 Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc Br J Cancer 79 11-12 1746 1751 10.1038/sj.bjc.6690278 10.1038/sj.bjc.6690278 10206287
21. B Schmalfeldt W Kuhn U Reuning, et al. 1995 Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2 Cancer Res 55 18 3958 3963 7664262
22. Agis H, Kandler B, Fischer MB et al. (2008) Activated platelets increase fibrinolysis of mesenchymal progenitor cells. J Orthop Res. doi: 10.1002/jor.20819
23. S Hsu-Lin CL Berman BC Furie, et al. 1984 A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets J Biol Chem 259 14 9121 9126 6746643
24. D Gurney GY Lip AD Blann 2002 A reliable plasma marker of platelet activation: does it exist? Am J Hematol 70 2 139 144 10.1002/ajh.10097 10.1002/ajh.10097 12111787 (Pubitemid 34553295)
25. GH Rao AT Rao 1994 Pharmacology of platelet activation-inhibitory drugs Indian J Physiol Pharmacol 38 2 69 84 8063366
26. H Kobayashi H Ohi M Sugimura, et al. 1992 Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B Cancer Res 52 13 3610 3614 1617632
27. O Wilhelm U Weidle S Hohl, et al. 1994 Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells FEBS Lett 337 2 131 134 10.1016/0014-5793(94)80259-9 10.1016/0014-5793(94)80259-9 8287966 (Pubitemid 24024158)
28. SJ Mandriota G Seghezzi JD Vassalli, et al. 1995 Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells J Biol Chem 270 17 9709 9716 10.1074/jbc.270.17.9709 10.1074/jbc.270.17. 9709 7730348
29. MS Pepper N Ferrara L Orci, et al. 1991 Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells Biochem Biophys Res Commun 181 2 902 906 10.1016/0006-291X(91)91276-I 10.1016/0006-291X(91)91276-I 1755866
30. CE Holmes JC Huang TR Pace, et al. 2008 Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer Clin Cancer Res 14 10 3070 3076 10.1158/1078-0432.CCR-07-4640 10.1158/1078-0432.CCR-07-4640 18483373
31. N Bozkurt K Yuce M Basaran, et al. 2004 Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer Obstet Gynecol 103 1 82 85 14704249
32. S Jain M Zuka J Liu, et al. 2007 Platelet glycoprotein Ib alpha supports experimental lung metastasis Proc Natl Acad Sci USA 104 21 9024 9028 10.1073/pnas.0700625104 10.1073/pnas.0700625104 17494758 (Pubitemid 47175430)
33. CS Alves MM Burdick SN Thomas, et al. 2008 The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion Am J Physiol Cell Physiol 294 4 C907 C916 10.1152/ajpcell.00463.2007 10.1152/ajpcell.00463.2007 18234849
34. M Trikha Z Zhou J Timar, et al. 2002 Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis Cancer Res 62 10 2824 2833 12019160
35. JS Palumbo KE Talmage JV Massari, et al. 2005 Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 1 178 185 10.1182/blood-2004-06-2272 10.1182/blood-2004-06-2272 15367435 (Pubitemid 40053080)
36. B Nieswandt M Hafner B Echtenacher, et al. 1999 Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res 59 6 1295 1300 10096562
37. G Kristiansen C Denkert K Schluns, et al. 2002 CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival Am J Pathol 161 4 1215 1221 12368195
38. K Suzuki K Aiura M Ueda, et al. 2004 The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents Pancreas 29 2 132 140 10.1097/00006676-200408000-00008 10.1097/00006676- 200408000-00008 15257105 (Pubitemid 38971803)
39. W Siess EG Lapetina 1990 Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition Biochem J 271 3 815 819 1700902
40. AW Chung P Jurasz MD Hollenberg, et al. 2002 Mechanisms of action of proteinase-activated receptor agonists on human platelets Br J Pharmacol 135 5 1123 1132 10.1038/sj.bjp.0704559 10.1038/sj.bjp.0704559 11877318
41. ML Kahn M Nakanishi-Matsui MJ Shapiro, et al. 1999 Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin J Clin Invest 103 6 879 887 10.1172/JCI6042 10.1172/JCI6042 10079109
42. TK Vu DT Hung VI Wheaton, et al. 1991 Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation Cell 64 6 1057 1068 10.1016/0092-8674(91)90261-V 10.1016/0092-8674(91)90261-V 1672265
43. ML Nierodzik S Karpatkin 2006 Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype Cancer Cell 10 5 355 362 10.1016/j.ccr.2006.10.002 10.1016/j.ccr.2006.10.002 17097558 (Pubitemid 44693468)
44. R Dardik N Savion Y Kaufmann, et al. 1998 Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA Br J Cancer 77 12 2069 2075 9649116
45. A Janowska-Wieczorek M Wysoczynski J Kijowski, et al. 2005 Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer Int J Cancer 113 5 752 760 10.1002/ijc.20657 10.1002/ijc.20657 15499615 (Pubitemid 40101256)
46. A Janowska-Wieczorek LA Marquez-Curtis M Wysoczynski, et al. 2006 Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells Transfusion 46 7 1199 1209 10.1111/j.1537-2995.2006.00871.x 10.1111/j.1537-2995.2006.00871.x 16836568 (Pubitemid 44139495)
47. AM Sieuwerts JG Klijn SC Henzen-Logmans, et al. 1999 Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro Breast Cancer Res Treat 55 1 9 20 10.1023/A:1006190729866 10.1023/A:1006190729866 10472775 (Pubitemid 29353970)
48. GC Rodriguez C Haisley J Hurteau, et al. 2001 Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta Gynecol Oncol 80 2 245 253 10.1006/gyno.2000.6042 10.1006/gyno.2000.6042 11161867 (Pubitemid 32158466)
49. SR Shiou PK Datta P Dhawan, et al. 2006 Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta J Biol Chem 281 45 33971 33981 10.1074/jbc.M607010200 10.1074/jbc.M607010200 16959768 (Pubitemid 46036608)
50. P Mehta 1984 Potential role of platelets in the pathogenesis of tumor metastasis Blood 63 1 55 63 6360248
51. TB Pustilnik V Estrella JR Wiener, et al. 1999 Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells Clin Cancer Res 5 11 3704 3710 10589790
52. OD Gil C Lee EV Ariztia, et al. 2008 Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner Gynecol Oncol 108 2 361 369 10.1016/j.ygyno.2007.10.027 10.1016/j.ygyno.2007.10.027 18073130
53. A Amirkhosravi SA Mousa M Amaya, et al. 2003 Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454 Thromb Haemost 90 3 549 554 12958625
54. ML Nierodzik A Klepfish S Karpatkin 1995 Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo Thromb Haemost 74 1 282 290 8578473
55. JP Stone DD Wagner 1993 P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer J Clin Invest 92 2 804 813 10.1172/JCI116654 10.1172/JCI116654 7688763
56. JE Italiano Jr JL Richardson S Patel-Hett, et al. 2008 Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released Blood 111 3 1227 1233 10.1182/blood-2007-09-113837 10.1182/blood-2007-09-113837 17962514 (Pubitemid 351213404)
57. D Alonso-Escolano AY Strongin AW Chung, et al. 2004 Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins Br J Pharmacol 141 2 241 252 10.1038/sj.bjp. 0705606 10.1038/sj.bjp.0705606 14691052 (Pubitemid 38250894)